The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.
Male Circumcision at Different Ages in Rwanda: A Cost-Effectiveness Study
Open accessAbstract
BACKGROUND: There is strong evidence showing that male circumcision (MC) reduces HIV infection and other sexually transmitted infections (STIs). In Rwanda, where adult HIV prevalence is 3%, MC is not a traditional practice. The Rwanda National AIDS Commission modelled cost and effects of MC at different ages to inform policy and programmatic decisions in relation to introducing MC. This study was necessary because the MC debate in Southern Africa has focused primarily on MC for adults. Further, this is the first time, to our knowledge, that a cost-effectiveness study on MC has been carried out in a country where HIV prevalence is below 5%. METHODS AND FINDINGS: A cost-effectiveness model was developed and applied to three hypothetical cohorts in Rwanda: newborns, adolescents, and adult men. Effectiveness was defined as the number of HIV infections averted, and was calculated as the product of the number of people susceptible to HIV infection in the cohort, the HIV incidence rate at different ages, and the protective effect of MC; discounted back to the year of circumcision and summed over the life expectancy of the circumcised person. Direct costs were based on interviews with experienced health care providers to determine inputs involved in the procedure (from consumables to staff time) and related prices. Other costs included training, patient counselling, treatment of adverse events, and promotion campaigns, and they were adjusted for the averted lifetime cost of health care (antiretroviral therapy [ART], opportunistic infection [OI], laboratory tests). One-way sensitivity analysis was performed by varying the main inputs of the model, and thresholds were calculated at which each intervention is no longer cost-saving and at which an intervention costs more than one gross domestic product (GDP) per capita per life-year gained. RESULTS: Neonatal MC is less expensive than adolescent and adult MC (US$15 instead of US$59 per procedure) and is cost-saving (the cost-effectiveness ratio is negative), even though savings from infant circumcision will be realized later in time. The cost per infection averted is US$3,932 for adolescent MC and US$4,949 for adult MC. Results for infant MC appear robust. Infant MC remains highly cost-effective across a reasonable range of variation in the base case scenario. Adolescent MC is highly cost-effective for the base case scenario but this high cost-effectiveness is not robust to small changes in the input variables. Adult MC is neither cost-saving nor highly cost-effective when considering only the direct benefit for the circumcised man. CONCLUSIONS: The study suggests that Rwanda should be simultaneously scaling up circumcision across a broad range of age groups, with high priority to the very young. Infant MC can be integrated into existing health services (i.e., neonatal visits and vaccination sessions) and over time has better potential than adolescent and adult circumcision to achieve the very high coverage of the population required for maximal reduction of HIV incidence. In the presence of infant MC, adolescent and adult MC would evolve into a "catch-up" campaign that would be needed at the start of the program but would eventually become superfluous. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Newborn male circumcision only requires a safe, rapid, one-time intervention and has been reported to be not only highly cost-effective but also cost saving.13”
From Rapid Training and Implementation of the Pollock Technique, a Safe, Effective Newborn Circumcision Procedure, in a Low-Resource Setting (2015) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Newborn male circumcision only requires a safe, rapid, one-time intervention and has been reported to be not only highly cost-effective but also cost saving.13”
From Rapid Training and Implementation of the Pollock Technique, a Safe, Effective Newborn Circumcision Procedure, in a Low-Resource Setting (2015) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Not Available, N. A. (2003) · Education for Health: Change in Learning & Practice · doi:10.1080/1357628031000116808 · Cited by 6,046
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451 · cited 3×
“The study in South Africa shows that MC generates large net savings after adjustment for averted HIV medical costs.”
BackgroundMale circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292 · cited 1×
“Conclusive evidence from three randomised control trials conducted in Uganda, Kenya, and South Africa showed that MC reduces the risk of HIV infection by about 55%: 51% in Uganda [3], 53% in Kenya [4], and 60% in South Africa [5].”
BackgroundMale circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226
The Survival Benefits of AIDS Treatment in the United States
Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/505147 · Cited by 581 · cited 1×
“For perperson years of survival under treatment we referred to the average life expectancy under care as reported by the US-based Walensky study corresponding to a time in the US before treatment of patients with multidrug resistance was available (and approximating the situation in Rwanda today) [22].”
MethodMale circumcision for the prevention of HSV-2 and HPV infections and syphilis.
Tobian, A. A. R., Serwadda, D., Quinn, T. C., Kigozi, G., Gravitt, P. E., Laeyendecker, O., Charvat, B., Ssempijja, V., Riedesel, M., Oliver, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802556 · Cited by 512
Singh-Grewal, D. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2004.049353 · Cited by 442 · cited 1×
“63) [8]; invasive penile cancer [9]; and reduces prevalence of human papillomavirus (HPV) (adjusted RR 0.”
BackgroundWeiss, H. A., Thomas, S. L., Munabi, S. K., & Hayes, R. J. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.017442 · Cited by 382 · cited 1×
“Studies also report a substantially reduced risk of other sexually transmitted infections (STIs) among circumcised men, such as syphilis (summary risk ratio [RR] = 0.67, 95% confidence interval [CI] 0.54–0.83) and chancroid (RR 0.12–1.11)”
BackgroundInfluentialCost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting
Kahn, J. G., Marseille, E., & Auvert, B. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030517 · Cited by 240 · cited 4×
“The study in South Africa shows that MC generates large net savings after adjustment for averted HIV medical costs.”
BackgroundMethodInfluentialMale circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
White, R. G., Glynn, J. R., Orroth, K. K., Freeman, E. E., Bakker, R., Weiss, H. A., Kumaranayake, L., Habbema, J. D. F., Buvé, A., & Hayes, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830e0137 · Cited by 115 · cited 1×
“[16] also found that MC is a cost-saving intervention in a wide range of scenarios of HIV and baseline circumcision prevalence.”
Background
Cited by
Chao, T. E., Sharma, K., Mandigo, M., Hagander, L., Resch, S. C., Weiser, T. G., & Meara, J. G. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70213-x · Cited by 369
Njeuhmeli, E., Forsythe, S., Reed, J., Opuni, M., Bollinger, L., Heard, N., Castor, D., Stover, J., Farley, T., Menon, V., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001132 · Cited by 318
“Our VMMC unit cost, which is higher than that used in previous studies [8,11,59,61,62], reflects a better understanding of the service delivery components required for such a program, including waste management and logistics associated with the scaling up of VMMC services [52].”
MethodCost‐effectiveness of Surgery in Low‐ and Middle‐income Countries: A Systematic Review
Grimes, C. E., Henry, J. A., Maraka, J., Mkandawire, N. C., & Cotton, M. (2014) · World Journal of Surgery · doi:10.1007/s00268-013-2243-y · Cited by 248
“29 [14, 15, 22–27].”
BackgroundMale circumcision and penile cancer: a systematic review and meta-analysis
Larke, N. L., Thomas, S. L., dos Santos Silva, I., & Weiss, H. A. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9785-9 · Cited by 205
“Circumcision services among adults are currently being expanded as an HIV prevention strategy [20] and neonatal/ infant circumcision is emerging as a cost-effective longterm HIV prevention strategy [41].”
BackgroundA 'snip' in time: what is the best age to circumcise?
Morris, B. J., Waskett, J. H., Banerjee, J., Wamai, R. G., Tobian, A. A. R., Gray, R. H., Bailis, S. A., Bailey, R. C., Klausner, J. D., Willcourt, R. J., et al. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-20 · Cited by 135
“Net cost per HIV infection averted in Rwanda was US$3,932 for adolescent circumcision and US$4,949 for adult circumcision [11].”
BackgroundInfluential
Metadata
- Authors
- Binagwaho, A., Pegurri, E., Muita, J., & Bertozzi, S.
- Affiliations
- Joint United Nations Programme on HIV/AIDS (CH)
- United Nations Children's Fund (US)
- Instituto Nacional de Salud Pública (MX)
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-19
- Volume
- 7
- Issue
- 1
- Pages
- e1000211
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2808207
- OpenAlex
- W2035967521
- Cited by
- 114
- References
- 12
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 14 · 2016: 15 · 2015: 7 · 2014: 5 · 2013: 13 · 2012: 13
- FWCI
- 16.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Surgery › Genital Health and Disease
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Female Genital Mutilation/Cutting Issues
- Keywords
- male circumcision, HIV prevention, cost-effectiveness, neonatal circumcision, adult circumcision, HIV incidence, Rwanda, HIV prevention policy, cost-effectiveness threshold, antiretroviral therapy costs, sexually transmitted infections, health care costs, sensitivity analysis, life-years gained, health campaigns, adverse events
- MeSH terms
- Adolescent, Adult, Age Factors, Circumcision, Male, Cost-Benefit Analysis, Developing Countries, Humans, Infant, Newborn, Male, Middle Aged, National Health Programs, Rwanda, HIV Infections, Incidence, Cost Savings, Health Care Costs, Models, Economic, Men's Health, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Male Circumcision at Different Ages in Rwanda: A Cost-Effectiveness Study. https://app.cochat.ai/papers/10.1371/journal.pmed.1000211
- The paper
- Binagwaho, A., Pegurri, E., Muita, J., & Bertozzi, S. (2010). Male Circumcision at Different Ages in Rwanda: A Cost-Effectiveness Study. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1000211
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
